文献速递糖尿病肥胖与代谢综合征

青年期空腹血糖变异性与糖尿病、心血管疾病及全因死亡风险

Fasting glucose variability in young adulthood and incident diabetes, cardiovascular disease and all-cause mortality.
PubMed 文献 · Diabetologia · 2019-05-22

基于CARDIA队列3769名18-30岁基线参与者随访至多30年,评估青年期空腹血糖长期个体内变异性与 incident 糖尿病、心血管疾病(CVD)及死亡的关系。校正多因素后,空腹血糖平均真实变异性(ARV-FG)每升高1个标准差,糖尿病风险HR 1.64(95%CI 1.52,1.78)、CVD风险HR 1.15(95%CI 1.01,1.31)、死亡风险HR 1.25(95%CI 1.11,1.40)。

要点

  • 青年期空腹血糖个体内变异性越高,远期糖尿病、CVD和死亡风险增加。
  • ARV-FG每升高1个标准差,糖尿病风险HR 1.64,CVD风险HR 1.15,死亡风险HR 1.25。
  • CV-FG与糖尿病和CVD风险相关,但与死亡风险关联无统计学意义。

核心结论

  • 青年期糖尿病发病前较高的空腹血糖个体内变异性与 incident 糖尿病、CVD及死亡风险相关。

研究设计与样本

  • CARDIA研究纳入基线1985-1986年18-30岁参与者3769名,随访至多30年共8次检查。
  • 长期血糖变异性采用空腹血糖变异系数(CV-FG)和平均真实变异性(ARV-FG)评估。

主要发现

  • 随访期间发生317例 incident 糖尿病(102,677人年)、159例 incident CVD(110,314人年)和174例死亡(111,390人年)。
  • 校正后ARV-FG每升高1个标准差,糖尿病HR 1.64(95%CI 1.52,1.78),CVD HR 1.15(95%CI 1.01,1.31),死亡HR 1.25(95%CI 1.11,1.40)。
  • 校正后CV-FG每升高1个标准差,糖尿病HR 1.39(95%CI 1.21,1.58),CVD HR 1.32(95%CI 1.13,1.54),死亡HR 1.08(95%CI 0.92,1.27)。
  • ARV-FG每升高1个标准差,非CVD死亡原因别HR 1.29(95%CI 1.14,1.47),CVD死亡原因别HR 1.05(95%CI 0.76,1.45)。
  • 未观察到性别或种族对任何关联存在效应修饰的证据。

临床怎么用

  • 青年期可关注空腹血糖的长期个体内变异性,作为远期糖尿病和心血管风险的辅助评估指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: The aim of this study was to determine whether long-term intra-individual variability in fasting glucose (FG) during young adulthood is associated with incident diabetes, cardiovascular disease (CVD) and mortality. METHODS: We included participants from the Coronary Artery Risk Development in Young Adults (CARDIA) study, ages 18-30 years at baseline (1985-1986) and followed with eight examinations for up to 30 years. Long-term glucose variability was assessed using the CV (CV-FG) and the absolute difference between successive FG measurements (average real variability; ARV-FG). For participants who developed any event (diabetes, CVD or mortality), FG variability measurement was censored at the examination prior to event ascertainment. We estimated HRs for incident diabetes, CVD and mortality with adjustment for demographics, baseline FG, change in FG (censor - baseline) and time-varying education, smoking, alcohol consumption, BMI, physical activity, systolic BP, BP medications, LDL-cholesterol and cholesterol medications (and incident diabetes and diabetes medications for CVD and mortality outcomes). RESULTS: Among 3769 black and white participants, there were 317 incident diabetes cases (102,677 person-years), 159 incident CVD events (110,314 person-years) and 174 deaths (111,390 person-years). After adjustment, HRs per 1 SD higher ARV-FG were 1.64 (95% CI 1.52, 1.78) for diabetes, 1.15 (95% CI 1.01, 1.31) for CVD and 1.25 (95% CI 1.11, 1.40) for mortality. The HRs per 1 SD higher CV-FG were 1.39 (95% CI 1.21, 1.58) for diabetes, 1.32 (95% CI 1.13, 1.54) for CVD and 1.08 (95% CI 0.92, 1.27) for mortality, after adjustment. The cause-specific HRs per 1 SD higher ARV-FG were 1.29 (95% CI 1.14, 1.47) for non-CVD death and 1.05 (95% CI 0.76, 1.45) for CVD death. We did not observe evidence for effect modification of any association by sex or race. CONCLUSIONS/INTERPRETATION: Our results suggest that higher intra-individual FG variability during young adulthood before the onset of diabetes is associated with incident diabetes, CVD and mortality.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Bancks MP, Carson AP, Lewis CE, et al. Fasting glucose variability in young adulthood and incident diabetes, cardiovascular disease and all-cause mortality. Diabetologia. 2019. PMID: 31115643. doi:10.1007/s00125-019-4901-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。